Sangamo Therapeutics (NASDAQ:SGMO) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Sangamo Therapeutics beat estimated earnings by 23.53%, reporting an EPS of $-0.26 versus an estimate of $-0.34.
Revenue was up $2.19 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 0.73% increase in the share price the next day.
Here’s a look at Sangamo Therapeutics’s past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.34 | -0.31 | -0.30 | -0.21 |
| EPS Actual | -0.33 | -0.33 | -0.32 | -0.29 |
| Revenue Estimate | 25.19M | 26.48M | 23.98M | 32.15M |
| Revenue Actual | 28.56M | 27.87M | 26.28M | 25.80M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
